IMUNOHISTOCHEMISTRY NAPSIN-A Test
Cost: AED 500.0
Test Name: IMUNOHISTOCHEMISTRY NAPSIN-A Test
Components: NAPSIN-A Test
Price: 500.0 AED
Sample Condition: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Report Delivery: Sample Daily by 6 pm; Report Block: 5 days, Tissue Biopsy: 5 days, Tissue large complex: 7 days
Method: Immunohistochemistry
Test type: Cancer
Doctor: Oncologist, Pathologist
Test Department:
Pre Test Information: Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Test Details
The NAPSIN-A test is an immunohistochemistry (IHC) test used in pathology to detect the presence of Napsin-A protein in tissue samples. Napsin-A is an enzyme that is primarily expressed in the lung, specifically in type II pneumocytes and alveolar macrophages. It is commonly used as a marker for lung adenocarcinoma, as it is highly expressed in this type of cancer.
The NAPSIN-A test involves staining tissue sections with specific antibodies that bind to Napsin-A protein. The antibodies are usually labeled with a colored or fluorescent marker, allowing for visualization under a microscope. If Napsin-A is present in the tissue sample, it will be detected as a positive staining signal.
The NAPSIN-A test is often performed in conjunction with other IHC markers, such as TTF-1 (thyroid transcription factor-1), to aid in the diagnosis and classification of lung adenocarcinoma. The results of the NAPSIN-A test can help pathologists determine the origin of a tumor and differentiate lung adenocarcinoma from other types of lung cancer or metastatic tumors.
Overall, the NAPSIN-A test is a valuable tool in the field of pathology for the identification and characterization of lung adenocarcinoma, helping guide treatment decisions and prognosis assessment for patients with this type of cancer.
Test Name | IMUNOHISTOCHEMISTRY NAPSIN-A Test |
---|---|
Components | |
Price | 500.0 AED |
Sample Condition | Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
Report Delivery | Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days |
Method | Immunohistochemistry |
Test type | Cancer |
Doctor | Oncologist, Pathologist |
Test Department: | |
Pre Test Information | Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
Test Details |
The NAPSIN-A test is an immunohistochemistry (IHC) test used in pathology to detect the presence of Napsin-A protein in tissue samples. Napsin-A is an enzyme that is primarily expressed in the lung, specifically in type II pneumocytes and alveolar macrophages. It is commonly used as a marker for lung adenocarcinoma, as it is highly expressed in this type of cancer. The NAPSIN-A test involves staining tissue sections with specific antibodies that bind to Napsin-A protein. The antibodies are usually labeled with a colored or fluorescent marker, allowing for visualization under a microscope. If Napsin-A is present in the tissue sample, it will be detected as a positive staining signal. The NAPSIN-A test is often performed in conjunction with other IHC markers, such as TTF-1 (thyroid transcription factor-1), to aid in the diagnosis and classification of lung adenocarcinoma. The results of the NAPSIN-A test can help pathologists determine the origin of a tumor and differentiate lung adenocarcinoma from other types of lung cancer or metastatic tumors. Overall, the NAPSIN-A test is a valuable tool in the field of pathology for the identification and characterization of lung adenocarcinoma, helping guide treatment decisions and prognosis assessment for patients with this type of cancer. |